Treatment of cystic fibrosis-related diabetes - Authors' reply

Lancet Diabetes Endocrinol. 2018 Mar;6(3):167-168. doi: 10.1016/S2213-8587(18)30043-3.

Authors

Manfred Ballmann¹, Reinhard W Holl²

Affiliations

¹ Paediatric Clinic, University Medicine Rostock, Rostock 18057, Germany. Electronic address: manfred.ballmann@med.uni-rostock.de.
² Institute of Epidemiology and Medical Biometry (ZIBMT), University of Ulm, Ulm, Germany; German Centre for Diabetes Research (DZD), Munich Neuherberg, Germany.

PMID: 29475493
DOI: 10.1016/S2213-8587(18)30043-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Cystic Fibrosis*
Diabetes Mellitus*
Humans
Hypoglycemic Agents

Substances

Hypoglycemic Agents